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Abstract
Hip replacement is one of the most performed surgical procedures in orthopedic 
hip surgery. Through this surgery, the patient returns to most of his normal life and 
a life without pain. The primary indication for a hip arthroplasty remains osteoar-
thritis (OA). OA is a degenerative disease that affects synovial joints. A successful 
surgery is always preceded by good planning. The planning in turn takes into 
account the analysis of the patient and his physical examination and the radiological 
image. But also, the surgical planning must take into account another important 
factor, the choice of the surgical approach. In this chapter, the authors script a revi-
sion on the history of hip arthroplasty, total hip arthroplasty approaches, implant 
types, complications associated with hip arthroplasty, outcomes, and perspectives 
to the future. We wish you a good reading.
Keywords: bone biology, hip arthroplasty, total hip arthroplasty, orthopedic
1. Introduction and history of hip arthroplasty
The hip arthroplasty is considered one of the greatest achievements of modern 
orthopedics [1, 2]. Through this surgery the patient returns to most of his normal 
life and a life without pain [3]. The primary indication for a hip arthroplasty 
remains osteoarthritis (OA). OA is a degenerative disease that affects synovial joints 
[4]. Because of the rapid recovery and return to most of the activities of daily living, 
hip arthroplasty was considered one of the few medical procedures with great 
benefit to the patient as a whole [5], and this surgery was considered the operation 
of the century by one of the most important medical journals in 2007 [3].
Hip arthroplasty began in Berlin in the late nineteenth century. Themistocles 
Gluck fashioned heads in ivory to replace the femoral head. This is the first concept 
of partial hip arthroplasty or hemiarthroplasty prosthesis. Gluck did these experi-
ments in human patients with hip tuberculosis. These experiments demonstrated 
that the human body is tolerant to foreign bodies [6, 7]. Schmaltz (1817) and White 
(1821) underwent hip resection arthroplasty for children patients with hip tuber-
culosis, and they had been successful. This technique was described by Girdlestone 
in 1943 [8]. Smith-Petersen in Boston (1923) developed studies coating prosthetic 
glass, bakelite, and synthetic resin [9]. Philip Wiles (1938) [10] in London brought 
the concept of a femoral head attached to a rod. The first concept of an acetabular 
reaming was developed, so was born the concept of total hip arthroplasty (THA). 
Sir John Charnley [11] was the orthopedist who changed the concept of THA. His 
early experiments with Teflon have failed. But he developed the concepts of 
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low-friction arthroplasty [12] provided by decreasing the friction area due to the 
reduction in the diameter of the femoral head (22 mm). And, he used the high-
molecular-weight polyethylene associated with methyl methacrylate (cement) [13] 
developed by Leon Wiltse in Los Angeles. These concepts of alliance were the con-
cepts that changed the course of history of THA surgery. Notice that Haboush was 
the first orthopedic surgeon to use prosthesis with this cement. Muller was another 
important surgeon who introduced the prosthesis design with a 32-mm-diameter 
head [9]. But problems related to cementation generate concerns to improve the 
cementing techniques. But it was not just that, the search for a better cementation 
techniques grew. Miller [14] developed the low-viscosity cement, Harris [15, 16] 
describes techniques for improving cementing, and Robin Ling [17] emphasized the 
pressurization of the cement in the femoral canal. Despite the problems of cement-
ing, orthopedic surgeons sought new fixation techniques. Pioneers in the area Pillar 
[18, 19] and Galante [20] introduced the concepts of cementless prosthetic com-
ponents and the bone growth and pressurization (press fit). The hip arthroplasty 
surgery is still currently growing and developing. There are several new possibili-
ties: articular surfaces of materials with less friction, more resistant materials, and 
minimally invasive techniques.
In this chapter, the major aspects of THA surgery will be addressed.
2. Total hip arthroplasty approaches
A successful surgery is always preceded by good planning. The planning in 
turn takes into account the analysis of the patient and his physical examination 
and the radiological image. But also, the surgical planning must take into account 
another important factor, the choice of the surgical approach. The lateral, anterior, 
and posterior are the main approaches to perform hip arthroplasty. The Moore 
approach, also named posterior approach [21], is the most used surgical approach. 
The visibility of the surgical field is wide, and the anatomical approach when 
known by the surgeon becomes fast and easily accessible. Acetabular and femoral 
reaming becomes easy to perform due to extensive visibility. Even with an extensive 
visibility, some authors reported an increased incidence of luxation when this 
approach is compared to the lateral approach. However, other studies have shown 
that there is no such correlation [22, 23] and these authors attributed the excessive 
luxation to the incorrect position of the prosthetic components [22, 23]. Another 
great and important positive point of this surgical approach is that it does not harm 
the abductor tendons, so it does not cause limping for operated patients. The lower 
frequency of deep vein thrombosis (DVT) and bleeding is attributed to this surgi-
cal access [22–27]. The anterior surgical approach described by Smith-Petersen 
[28] and Hueter [29] is less used today, but it has gained new and notorious space 
among hip surgeons, due to its facilities and strengths for not detaching tendons 
and muscles. In the same way today, this approach is being used in less invasive and 
less aggressive surgeries, with the so-called mini-open approach. To the anterior 
approach, appropriate surgical instruments are needed, and the chance for lesion to 
occur in the femoral cutaneous nerve during surgery is elevated [30]. The last of the 
three most commonly used approaches is the direct lateral approach or Hardinge 
[31]. It has been the most used surgical technique. Hardinge approach is useful 
because it allows easy placement of the components and it is a familiar approach to a 
large number of surgeons. This feature makes Hardinge one of the most widely used 
approaches. Some authors attribute to this approach lower luxation rates than the 
posterior approach of Moore. But its drawback is that it is able to injure the abductor 
muscles and cause limping in the patient [22–24].
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3. Implant types
The choice of the implant type must also be regarded as extremely important 
to the success of the surgery. Basically, the implants used in hip arthroplasty can 
be divided into two groups: non-cemented (cementless implants) and cemented. 
This division is in regard to the different ways of fixation of the implant to the 
host patient bone. The main characteristic that distinguishes them is the presence 
or absence of bone cement (polymethyl methacrylate (PMMA)). Alternatively, a 
hybrid implant may be used, i.e., a component is fixed with PMMA and other not.
The cemented implants wear the interposition of a polymer called PMMA as an 
interface between the patient’s bone and the implant. This form of attachment was 
designed by Haboush and subsequently disseminated by Charnley in the 1960s [32]. 
PMMA has a modulus of elasticity very close to the human bone elasticity modulus 
(elasticity modulus cement +2GPa; elasticity modulus of trabecular bone +0.5–
1GPa). This polymer is very resistant to compressive forces but does not have good 
resistance to tension or shearing forces [33]. The long-term results to cemented 
implants depend on the quality of the cement mantle both in the acetabulum and 
in the femur. Initially, the placement of the cement manually, without the use of 
distal plug in the femoral canal, was used. The cement mixture was done manually, 
and pressurization into the canal was performed digitally. This technique was first 
called as the generation cementing technique. The retrograde filling of the femoral 
canal with the aid of cement pistols was later developed. They began to use femoral 
canal plug or plug restrictors, which aims to create a distal barrier to the stem that 
prevents the passage of cement and favors the pressurization and interdigitation of 
PMMA in the trabecular bone [34]. These advances represent the second generation 
of cementation. In the third generation, special techniques were introduced to the 
cement mixture (vacuum mixing or mixture in centrifuge). However, these special 
techniques for cement mixing are controversial and do not seem to improve the 
mechanical properties of PMMA [35]. One of the parameters often used to define 
an appropriate cementation is the presence of a uniform cement mantle, that is, 
with no bubbles or lines of radiolucency between the cement and the bone [36]. The 
thickness of the PMMA mantle is another parameter to define appropriate cementa-
tion. In this case, a thickness of 2 mm of the mantle between the femoral stem and 
the bone is considered adequate [36]. In the acetabulum, the mantle must have a 
thickness of 3 mm [37]. This trivial standard of cementation has the contrast of the 
controversial “French paradox,” a way of cementation in which the femoral canal is 
filled with the largest possible stem by using the PMMA to fill the remaining spaces, 
sometimes getting fine and nonuniform mantels [38]. Other aspects in cemented 
implants to be observed carefully are:
1. Design—Cemented femoral stems can be classified as simple wedge, double 
wedge, or triple wedge according to the geometry of the implant. Typical repre-
sentatives of these subcategories are the stems of Charnley, Exeter, and C-stem, 
respectively [39]. Although the triple-wedge stems have lower stress in the 
cement mantle [40], a higher posterior rotation of this implant model is reported 
[41]. The clinical implications of these findings in the triple-wedge stem are not 
yet known, and yet this stem type has not demonstrated superiority over other 
designs [42]. Currently, the stems in double wedge are most often used.
2. The covering of the implant—Traditionally, the best results are obtained with 
polished implants, i.e., smooth rods. There are femoral stems with rough 
surface, but these implants are not widely accepted, and its long-term results 
are not well established in large series [43].
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3. The implant material—Usually, the implants are made of chrome-cobalt alloys 
or stainless steel. Titanium implants were tested; however, the results were 
very short compared to the traditional metal alloy [44].
The cementless implant aims to obtain a biological fixation between the implant 
and the host bone. Summarized there is the expectation of bone growth to the 
porosity of the implant and thus its final attachment to the bone. Unlike cemented 
implants, the presence of porosity is an indispensable requisite for fixation. There 
is the use of PMMA in this technique of placing the uncemented prosthesis. The 
implants do not depend on the cemented macrolocking (primary fixation) and 
microlocking (secondary fixation). Macrolocking must occur upon insertion of the 
implant, being obtained by an intimate fit of the implant to the bone. Microlocking 
is due to the bone ingrowth, i.e., the formation of bony bridges between the host 
bone and the pores of the implant [45, 46]. Ultimately, this is the factor that deter-
mines the longevity and success of a cementless implant. Macrolocking or primary 
locking can be obtained by various techniques, dependent or not in changes in the 
design of the implant, such as screw fixing, flaps, or grooves. Currently, the most 
common technique in primary stabilization is the press fit. This type of stabiliza-
tion requires the placement of the prosthesis in an undersized cavity. In cementless 
acetabular beyond the press fit, screws may also be used as an aid to the primary 
fixation; however, with a suitable press fit, screws can even be dispensed [46–48]. 
To bone ingrowth occur, macrolocking must produce sufficient stability in order to 
avoid micromotion. When micromotion occurs, even if slight, it can delay or pre-
vent the formation of bone tissue onto the implant, thus favoring the formation of 
fibrous tissue [46–49]. For microlocking, porosities are indispensable in the implant 
surface. Thus, it becomes extremely important different characteristics of the 
pores, as its size, its geometry, and its interconnection. Studies show that the size of 
the pores should be between 100 and 400 μm. Pores smaller than 50 μm or greater 
than 500 μm facilitate the growth of fibrous tissue rather than bone tissue [49]. The 
pores may have different geometries. There are three traditional types of porosity: 
the plasma-sprayed coating, the sintered sphere coating, and the fiber mesh coating 
[49]. In recent years, derived surfaces of trabecular metal porous coating has proven 
promising in the coverage or in the production of cementless implant, but results 
with longer follow-up are still waited. It is estimated that the percentage porosity is 
greater for the fiber mesh coating—between 40 and 50%—and the porous trabecu-
lar metal coating—between 75 and 80% [50]. The interconnection between the 
pores also plays an essential role in bone coupling force to the implant. If it is higher, 
the interconnection between the pores is resulting in major coupling force between 
the bone bridges and the prosthesis. Theoretically, the form of the manufacturing 
fiber mesh coating and the trabecular metal coating allows for a better intercon-
nection between the pores compared to the plasma-sprayed coating and the sphere 
coating [47].
Another type of arthroplasty are considered hybrid. In this type of prosthe-
sis, one of the implants is cemented and the other does not. It was called hybrid 
arthroplasty prosthesis in the acetabulum, which is not a cemented and cementless 
femoral stem. The reverse, i.e., cemented and cementless acetabular rod, was called 
reverse hybrid arthroplasty.
With regard loading surfaces, tribology has also shown its importance in mod-
ern times and has contributed to the THA surgery that increased its longevity. The 
tribological pair most widely used and studied is the metal-polyethylene. Other 
tribological pairs are also used: ceramic-polyethylene, metal–metal, and ceramic–
ceramic; these last two tribological pairs are also called hard on hard. Currently, 
there is a trend in replacing the ultrahigh-molecular-weight polyethylene 
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(UHMWPE) by highly cross-linked polyethylene (XLPE). The XLPE result of 
a series of interventions during its production seeks to change the connections 
between the molecules, resulting in a harder and wear-resistant material [51]. 
It is estimated that 0.04 mm/year is the linear wear rate compared to the XLPE 
0:22 mm/year UHMWPE [52, 53]. All new tribological pairs presented as benefit 
a less volumetric wear, a fact that in theory could be beneficial for the longevity of 
the arthroplasty. There are, however, some peculiarities in these pairs. The metal–
metal surface has an extremely low volumetric wear; however, it is given to metal–
metal surface to release chromium and cobalt ions, which can be adsorbed and 
present local and systemic complications [54]. Among the local complications, 
pseudotumor formation is the major problem [55]. Systemic effects include neuro-
logical and cardiac damage [56]. There are also carcinogenic potential of systemic 
release of chromium and cobalt, although the exact impact of this exposure is not 
well known [57]. These systemic effects led to a metal–metal contraindicated in 
patients with allergies to metals and, in particular, women of childbearing age 
[58]. The ceramic–ceramic tribological pair has greater resistance to volumetric 
wear than metal–metal surface. This combination is particularly suitable for very 
young patients with high activity level and has no contraindication for women of 
childbearing age. The disadvantages of ceramic–ceramic are fracture risk and the 
risk of producing noise (squeaking) during hip movement and the stripe wear. 
The risk of squeaking is multifactorial; the main factors are the malposition of 
the components, the implant design, and the type of material used in manufac-
turing, though not always the trigger is recognized [59, 60]. The risk of ceramic 
fracture is currently between 0.004 and 0.010% being associated with the wrong 
positioning of the components (acetabular or femoral head) [61]. The stripe wear 
can occur when there is decreased contact area between the femoral head and 
acetabular surface, which can arise during swing phase of gait occurs or when the 
impingement of the trunnion on the acetabular rim and ball leaves right from the 
socket. The stripe wear is of concern due to the large volumetric wear it can cause. 
Individuals with tissue hyperlaxity or excellent range of motion (ROM) and those 
who require placing the hip through the extreme ROM are prone to impingement 
and consequent stripe wear [62]. The cross-linked polyethylene-ceramic surface 
adds the benefits of not releasing metal ions, no risk of squeaking besides present-
ing a very low volumetric wear, however higher than that of the hard-on-hard 
surfaces. As the head of ceramic is used, there is a minimal risk of fracture of the 
component. Perhaps, it represents a suitable alternative for young patients and 
factors that may complicate the use of other types of tribological pairs.
The proper choice of the type of implant, whether cemented or not, and the 
different tribological pairs should take into account the theoretical knowledge of 
the design features, materials, and long-term outcomes beyond the patient charac-
teristics and the surgeon’s experience.
4. Complications
Complications associated with hip arthroplasty can vary among groups of 
patients—age, gender, bone quality, and comorbid. For classification purposes 
it can be divided by time: acute complications, as in intraoperative and early 
adverse events—generally within 30–90 days, and late postoperative complica-
tions that can be divided in short-term and long-term complications. The most 
common major complications include mortality, infection, dislocation, revi-
sion, and thromboembolic events and will be the center of discussion in this 
section [63].
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4.1 Mortality
The indications for arthroplasty have been expanded during recent years. More 
patients, both younger and old, are operated now, and, in that case, the older group 
runs a particularly greater natural risk of serious complications. That implicates that 
higher-risk patients undergo operation than anteriorly. In most recent registries, the 
short-term mortality rate (90-day mortality) in all patients who undergo hip arthro-
plasty has an average value of 6.9% [64]. In that period, the dominant causes seem to 
be cardiac, cerebrovascular, or thromboembolic illnesses. Mortality at 90 days postop-
eratively in the US Medicare population has been reported as 1% for primary total hip 
arthroplasty [63]. That shows that mortality can vary significantly, especially when 
specific groups are studied. In other registries when we divided the mortality rate of 
partial primary hip replacement—usually used in elderly patients with fractures, we 
find a rate of 21.53 per 100 person-years. Otherwise, the total primary hip replace-
ment has a rate of 2.54 per 100 person-years [65].
4.2 Thromboembolism
Thromboembolism is a potentially catastrophic complication faced by all 
patients who undergo elective hip arthroplasty. During the 90 days following pri-
mary arthroplasty surgery, hospitalization due to symptomatic deep vein thrombo-
sis occurs in 0.7%, while hospitalization due to pulmonary embolism occurs in 0.3% 
[66]. In early reports prior of routine prophylaxis, venous thrombosis occurred as 
high as 50% of times in patients after total hip replacement [67]. In 2001, the sixth 
conference held by the American College of Chest Physicians came to the conclu-
sion that all patients undergoing total joint replacement needed to be placed in 
the highest-risk category for DVT [68]. Today, there are guidelines from different 
medical areas with the intent to patronize the use of drugs and to give information 
about the management of thromboembolic disease. Despite all the attempts to vali-
date and embrace the use of these guidelines, the ideal method of thromboembolic 
events prophylaxis remains controversial.
The general concern for total joint replacement surgeons, about these publica-
tions considered as high-level recommendations (1A), was the promotion of aggres-
sive treatment for all patients, regardless of their risk profile. In 2011 and 2012, 
reports from the FDA appointed that anticoagulants were the leading drug risk to 
patients and complications like bleeding, drainage, and wound complications were 
the critical counterpoint for routine aggressive prophylaxis [69].
Today, there is no current evidence whether factors other than a history of 
previous venous thromboembolism increase the risk of venous thromboembolism 
in patients undergoing elective hip arthroplasty [70]. There are many other factors 
that were appointed to increase risk, like, obesity, or advanced age, but there’s no 
real evidence to support. There is a consensus that any other factor that can cause 
decrease of mobility can be a risk factor, the same way for hemostatic abnormali-
ties that can cause hypercoagulable states. There are no image exams or laboratory 
markers that can indicate a greater risk for thromboembolism. Today, there is strong 
evidence against the routine use of ultrasound for the screening of patients after hip 
arthroplasty for DVT. Is important to bear in mind that, at least 50% of patients, 
diagnose is not clinically apparent.
The diagnosis of DVT is based in clinical findings, usually pain and tenderness in 
the calf or thigh, erythema, and swelling, most of the times unilateral. Venography 
still stands as the “gold standard” for confirmation of DVT, but the duplex ultra-
sound seems to be a low-cost, minimal morbidity, good sensitivity option, besides 
the risk of anaphylactic reaction to contrast and low chances of inducing DVT that 
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venography carries. Pulmonary embolism can curse with chest pain, breathlessness, 
and rapid pulse, and it’s a cause of sudden death. The diagnosis can be confirmed by 
pulmonary angiography.
The best method of prophylaxis still is not clear. There is evidence to suggest that 
pharmacological agents and/or mechanical compression devices reduce DVT rates 
in patients undergoing elective knee or hip arthroplasty. The results of analyses 
in recent studies did not consistently suggest that any one strategy is preferable 
to another. The most commonly used agents are low-molecular-weight heparin 
(LMWH), aspirin, direct factor Xa inhibitors (“xabans”), and warfarin. Devices 
of intermittent compression seem to be effective especially in distal emboli. There’s 
no consensus either for the time that prophylaxis is maintained. It varies for at least 
10 days as far as 35 days after surgery, depending on the patient and the drug. There 
has been a tendency to return the use of aspirin after hospital discharge [71].
It is a consensus, even when there’s no evidence to support, that patients under-
going elective hip or knee arthroplasty, and who also have a known bleeding dis-
order (e.g., hemophilia) and/or active liver disease, use a less aggressive treatment 
with mechanical compressive devices for preventing venous thromboembolism.
Early mobilization still is a low-cost, minimal risk to the patient and consistent 
method with the current practice. Mobilization as soon as possible following hip 
arthroplasty addresses the stasis limb of Virchow’s triad (hypercoagulability, 
endothelial injury, and stasis) promoting the regional blood flow and diminishing 
the risk for formation of clots.
4.3 Dislocation
Dislocation is one of the most feared complications after THA. Probably, it is 
one of the most common indications for revision surgery. An incidence from 1 to 
3% of dislocation after THA has been reported [72]. Risk factors include the type 
of surgical approach, previous surgery, obesity, fracture of proximal femur, mal-
positioning of components, impingement, insufficient abductor muscle, femoral 
component head sizes, and others. Many studies tried to isolated these causes, but 
there’s not much medical evidence to support, and the most common conclusion is 
that retrospective randomized trials examining dislocation rates and other clinical 
parameters are needed [73]. Clinical finding include pain, shortening, and internal 
or external rotation of the limb.
Factors like age, height, or race are seen to be associated with bias with at least 
one technical-related factor when the disclosure is dislocation. However, in many 
series, dislocation occurred in women more often than men.
The most used surgical approaches for THA are the posterior and direct lateral 
approaches. The posterior approach is considered to be easy to perform; however, 
increased rates of dislocation have been reported. The direct lateral approach was 
related to an increased risk of limp. Studies indicate that soft tissue repair reduces 
the relative risk of dislocation using the posterior approach and that the dislocation 
rate for these approaches becomes similar. It has been advocated that bigger head 
sizes increase instability and have greater ROM [22, 74, 75].
The vast majority of dislocations occur within 3 months of surgery. These early dis-
location (<6 months) presents higher chance of success with nonoperative treatment. 
Late complications, after 5 years in general, are more challenging to treat because of the 
many factors that can be attributed to these cases [72]. The combination of muscular 
weakness and malposition implants is seen to be the worst scenario for hip stability.
Besides all the discussion about head sizes and different approaches, the single, 
most effective way of preventing dislocation still is education of the patients and 
the people who assist them. They should be aware that which extreme movements 
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and which specific position are most likely to cause dislocation, and the ways of 
avoid them without lose their independence. It’s important that the patient is able to 
repeat and understand the instructions for precaution before hospital discharge and 
has reinforced these directions at follow-up routine.
The surgical options for treatment are as many as the causes for the dislocation can 
be. Change of components for longer and bigger heads, liner exchange, and elevated 
rim could be successful sometimes; otherwise, component revision, soft tissue 
reconstruction, or even constrained liner may be needed. Identifying the causes of 
instability after THA is essential for the correct approach and satisfactory outcome.
4.4 Nerve and vascular injuries
Nerve and vascular injuries are very uncommon complications in primary total 
hip replacement but can be the most distressing ones. With an incidence between 0.8 
and 3.5% for nerve injuries, the most common nerve damage followed by femoral 
nerve has been the sciatic nerve palsy [76]. These numbers can be altered when you 
observe a specific kind of approach, as with the anterior direct approach, that can 
present with up to 15% of lateral femoral cutaneous nerve palsy in some reports [77].
Several risk factors were identified for nerve injuries, including previous sur-
gery, revision procedures, type of approach, and excessive leg extension. However, 
no correlation between the amount of lengthening and nerve palsy in total arthro-
plasties performed for dysplasia of the hip has been reported [78]. Previous surgery 
or revisions were correlated with technically difficult in the surgical exposure, ana-
tomical abnormalities, and injudicious retraction. In order to diagnose nerve palsy 
after orthopedic surgery, an electromyogram can be of use to assess the extent and 
prognosis. According to the literature, partial recovery can be expected in 70–80% 
of cases. Latest reports appoint only 50% of full recovery after common peroneal 
nerve palsy following total hip arthroplasty with the mean time of 12–18 mouths 
depending on the severity of lesion. Other studies showed improvement beyond the 
limit of 2 years and independent of the nerve affected. Obesity was appointed as a 
factor that adversely influenced the nerve recovery [79, 80].
Vascular injury in primary hip arthroplasty is rare and most frequently associ-
ated with the use of screws for fixation of structural grafts, acetabular components, 
and protrusio rings or cages. The individual risk is determined by multiple fac-
tors depending on the surgeon’s skills, the number of previous surgeries, and the 
approach itself. The acetabular quadrant system as described by Wasielewski et al. is 
a useful tool to understand the neurovascular anatomy of the hip, to detect the safe 
zone, and subsequently prevents complications that can pose as a threat to the limb 
and the patient [81].
4.5 Fractures
The most common are those who affect the femur and are classified by the local 
of the fracture, the fixation of implant, and the bone stock of the femur. Can also 
be dived by time, as intraoperative and postoperative fractures, the most common 
being the intraoperative fractures of the femur with an uncemented steam.
There are moments during the procedure that the fracture is most likely to occur. 
One of the critical stages seems to be while attempting to dislocate the hip, especially 
in fragile bones of elderly patients and rheumatoid arthritis patients. During the stage 
of broaching or during the insertion of the implant, cortical defects and proximal 
deformities can elicit a fracture of the diaphysis. Acetabular fractures are much more 
uncommon also because often they are not recognized. The key moment is seen to be, 
with press-fit components, during the impaction of an underreamed acetabulum.
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The Vancouver classification of periprosthetic femoral fractures became known 
for postoperative fractures and was modified to include this intraoperative ones 
(Table 1).
The treatment can be initiated by taking preventive actions: the anticipation 
of anatomical challenges in preoperative planning and templating; the choice of 
implants, by the use of moderate rotational force and with wider approaches; and 
the liberation of soft tissues that might be restraining to the adequate exposure. 
Patients with osteoporotic bone, neuromuscular disorders, and previous hip surgery 
should be of higher concern. The use of fluoroscopy is an important tool to identify 
these fractures when suspected. Each type of fracture needs a specific treatment. In 
a review by Misur et al. [83], they summarize recommendations for the treatment 
of periprosthetic fractures of the femur with grading of published evidence sup-
porting each recommendation (Table 2). The need for adjunctive fixation should 
be assessed, extended approach for the correct assessment is often needed, and the 
result needs to present a stable construction. Clear orientation for the patient and 
family about weight-bearing and healing process of the fracture is essential for good 
results.
4.6 Infection
Periprosthetic joint infection remains a challenge for the orthopedic surgeons. It 
represents a risk for disastrous and painful consequences for the patients, especially 
for those submitted to elective primary joint replacement. The incidence reports 
approximately 1% of infection after THA. Great effort is applied to identify risk 
factors, minimize, and prevent these complications in a systematic way. Currently, 
recommendations are based in large, multicenter studies, but still high-level 
evidence for these practices are few, and many are based on little to none scientific 
Vancouver A Vancouver B Vancouver C
AG AL B1 B2 B3 C
Prosthetic fixation Stable Stable Stable Loose Loose Stable
Bone quality Good Good Good Good Poor Good
Table 1. 
Vancouver classification resume [82].
Type AG Nonoperative treatment if nondisplaced; open reduction and internal fixation if displaced 
fracture in active patient
Type AL Nonoperative treatment unless implant stability compromised
Type B1 Fixation with minimally invasive lateral locking plate; addition of allograft strut if bone stock 
compromised
Type B2 Revision with extensively coated tapered fluted stem (modular or nonmodular)
Type B3 Revision with extensively coated tapered fluted stem (modular or nonmodular); if bone stock 
grossly compromised, use allograft-prosthesis composite with megaprosthesis reserved for 
salvage procedures and elderly patients
Type C Fixation with minimally invasive lateral locking plate
Adapted from [84].
Table 2. 
Treatment of periprosthetic fractures of the femur after total hip arthroplasty.
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foundation whatsoever. In 2014, the Proceedings of the International Consensus 
Meeting on Periprosthetic Joint Infection in the attempt to unify the current knowl-
edge and practice was published.
Risk factors were divided as significant and potential risks for development of 
surgical site infection (SSI) or periprosthetic joint infection (PJI) after elective 
total joint arthroplasty (TJA). In the first category, 99% of the delegates consen-
sus that active infection of the arthritic joint (septic arthritis), presence of sep-
ticemia, and/or presence of active local cutaneous, subcutaneous, or deep tissue 
infection are all significant risk factors predisposing patients to and are contra-
indication to undertaking elective TJA. Ninety-four percent agree that history of 
the previous surgery, poorly controlled diabetes mellitus (glucose > 200 mg/L or 
HbA1C > 7%), malnutrition, morbid obesity (BMI > 40 Kg/m2), active  
liver disease, chronic renal disease, excessive smoking (>1 pack per day), exces-
sive alcohol consumption (>40 units per week), intravenous drug abuse, recent 
hospitalization, extended stay in a rehabilitation facility, male gender, diagnosis 
of posttraumatic arthritis, inflammatory arthropathy, prior surgical procedure 
in the affected joint, and severe immunodeficiency are potential risk factors for 
development of SSI or PJI [85].
Active infection in periodontal disease, methicillin-resistant Staphylococcus 
aureus (MRSA), and methicillin-sensitive Staphylococcus aureus (MSSA) colo-
nization were appointed as factors that can contribute to development of the 
infection, as well as urinary tract infection (UTI); however, there’s no medical 
evidence to support screening for these patients. Nevertheless, patients with 
a known history of recurrent urinary infection or for those with evidence of 
ongoing urinary symptoms suspicious for infection should receive special 
attention.
Antibiotic prophylaxis is, in general, the most important factor to reduce 
the chances of contaminating microorganisms to establish during the proce-
dure exposure. For that it’s important that, by the time of the incision, there is 
adequate tissue concentration of the drug. Most of the guidelines recommend 
that prophylactic antibiotics be completely infused within 1 hour before the 
surgical incision. A first- or second-generation cephalosporin is normally 
administered for routine perioperative surgical prophylaxis, mostly because of 
its broad spectrum of action, cost-effectiveness, and the need to preserve newer 
and more expensive therapies for drug-resistant microorganisms. Additionally, 
they have excellent distribution profiles in the bone, synovium, muscle, and 
hematomas. Patients who weigh more than 80 kg should receive double the 
amount of cefazolin usually used. The efficacy of 1 day of cefuroxime vs. 3 days 
of cefazolin on postoperative wound infections was tested and found to have no 
statistically significant difference between the two regimens [86]. An additional 
dose of antibiotic should be administered intraoperatively after two half-lives of 
the prophylactic agent or after important blood loss. The choice of antibiotics for 
patients with pre-existing prostheses such as heart valves is the same as that for 
routine elective arthroplasty.
If infection is suspected, it’s important to understand in what moment of the 
disease the patient presents himself because time is a relevant factor in approach-
ing these complications and might influence in the treatment options. There are 
many classifications; in general, they are divided as follows: (1) early postoperative 
infection that can vary between 3 and 6 weeks onset within the time of the surgery, 
depending on the author; (2) late chronic infection after these periods and with 
an insidious presentation of symptoms; and (3) acute hematogenous infection, 
defined by the onset after these 3 to 6 weeks in a previously well-functioning 
prosthesis, probably by a distant source of infection.
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The diagnosis still is in debate; the consensus is defined as PJI as follows:
• Two positive periprosthetic cultures with phenotypically identical organisms
• A sinus tract communicating with the joint
• Having three of the following minor criteria:
• Elevated serum C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)
• Elevated synovial fluid white blood cell (WBC) count OR ++change on leuko-
cyte esterase test strip
• Elevated synovial fluid polymorphonuclear neutrophil percentage (PMN%)
• Positive histological analysis of periprosthetic tissue
• A single positive culture
The AAOS’s algorithm (Figure 1) was adapted to be applied to patients who 
present with a painful or failed arthroplasty.
Figure 1. 
The AAOS’s algorithm for treatment to patients with a painful or failed arthroplasty [85].
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The major discussion nowadays among joint replacement hip surgeons is 
whether to perform a one-stage or two-stage revision in patients with diagnosis 
of infection. Patients with early postoperative infection apparently have strong 
chances of cure when an open debridement and change of mobile parts are realized 
as an early aggressive intervention [87].
Both procedures have the same intent: identification of the organisms; eradica-
tion of the foci; physical removal of any organism, tissue, or components that might 
have been exposed; appropriated treatment with antibiotics; and safe reconstruc-
tion of the joint in a healthy environment.
The bone cement loaded with antibiotics has been the main weapon in the 
one-stage enthusiasts, as the spacers have been for those who advocate four two-
stage revisions. The selection of patients has been seen to have an important role in 
that decision; the tendency has been the single-stage revision. With more studies 
published each year showing similar outcomes for both types of procedures, the 
social and economic advantages of one operation, like shorter hospitalization, early 
return to activities, and higher satisfaction rates, give the one-stage revision an 
increasing role in the treatment of joint infection.
5. Outcomes
The focus of THA registries traditionally has been on implant longevity and 
rates of revision surgery. The landmark of failure of the implant and the necessity of 
revision still are considered the best definition of clinical failure as well. Otherwise, 
the choice of parameters for the definition of failure, clinical or radiographic, 
could be troublesome. Short-term mortality rate (90 days postoperative) also has 
been used as an outcome. However, the latest publications signalize an important 
change in the outcome reports. Since pain, impaired joint function, and quality 
of life related to hip disease are the main indications for THA, thus to include this 
patient-related information in the results reported after primary hip replacement. 
The patient-reported outcome (PRO) includes pain relief, joint function, and other 
health-related quality-of-life improvements and represents an important aspect of 
hip arthroplasty results.
National joint registries are the most reliable and most quoted references when 
the subject is outcome. Through them it’s been possible to have a greater view 
and more profound understanding of why arthroplasties fail. For example, in the 
Norwegian report of 2002, 9.2% of 17,323 primary Charnley hip prosthesis implants 
were revised after 10 years of follow-up, and 71% of the failures involved aseptic 
loosening of the femoral component. The use of a specific type of cements was 
appointed as an important and highly significant probable cause in this percentage 
[88]. Another example was the metal-on-metal surface and the early complications 
reported in many registries. For that manner, reports became an essential tool 
to orthopedic surgeons to understand the impact of all these variables—implant 
design, material, patient selection, surgical techniques, and others—and how they 
are influencing the outcomes in their clinical practice.
In general the most common causes for revision are the same in every other 
registry or study published. Sometimes, the percentages can vary depending on 
the population studied. In the 2012 Swedish reports, for example, aseptic loosening 
including osteolysis was the most common cause for revision (28%), followed by 
dislocation (26%), infection (22%), and periprosthetic fracture (13%) [89].
One of the major areas of discussion has been cemented versus cementless 
implants and how they can influence in the outcome. An increasing use of unce-
mented implants in the last 10 to 15 years has been reported. Over the same time 
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period, there was a corresponding reduction in the use of cemented ones. The 
National Joint Registry for England, Wales, Northern Ireland and the Isle of Man of 
2014 reports that in 2003 cemented hip replacement was used in 60.5% in compari-
son to 33.2% in 2013. Otherwise, cementless increased from 16.8% in 2003 to 42.5% 
in 2013 [90]. The “new trend” defenses of uncemented implants are that it is faster 
surgically, avoids the third-body debris, and creates a biological interface of bone 
ingrown in the implant (and with that less rate of loosening) and less chances of 
embolic events that can occur during cementation. The cement users appoint that 
there are less fractures, intra- and postoperatively, less dislocation and leg length 
discrepancies, and less thigh pain report after surgery, and, mainly, there is registry 
data of better outcome in patients older than 75 years [91].
All these qualities or failures on both implants are, in fact, correct. Cemented hip 
arthroplasties have been reported to be better in many nation registries, especially 
in older patients [92, 93]. Otherwise, specific centers across the globe reported up to 
99% of cementless steam survival after 12–26 years of follow-up [94, 95]. There are 
reports of the accuracy during cup position, and cemented cups seem to have better 
position than uncemented cups that have the tendency to deviate from their original 
place [96]. The incidence of periprosthetic femoral fractures is becoming more 
common, and that could be attributed to the larger use of uncemented implants. 
Thigh pain is most common with uncemented femoral steams, but in a great way, 
this can be attributed to the design of the implant that was used. The major issue 
in using cemented implants still is the technique and its reproducibility. Perfect 
cementing technique is essential to achieve all these excellent results. Pulsatile jet-
lavage to clean the cancellous bone and allow the cement to have good interdigitat-
ing as well as good pressurization and homogenous cement mantle is appointed as 
prerequisite to reach adequate cementation [97].
Other important aspect of failure in hip arthroplasty has been between the 
implants that are used in partial arthroplasties. In the Australian report of 2014, 
in patients under the age of 75 years old after the neck of the femur fracture, the 
revision rate after 10 years for primary unipolar monoblock and unipolar modular 
hip replacement was the same (16.1%). To the same group of patients, the bipolar 
presents a 9% rate of revision in the same period of 10 years [93].
In primary hip replacement for osteoartrite (OA), nation registry reports are simi-
lar, in an overall of 5–6% rate of revision in 10 years for all ages. When divided by the 
type, the British reports 3.2% for all cemented, 7.68% to all cementless implants, and a 
total of 3.95% for hybrids. The Australian reports 6, 5.4, and 4.8%, respectively. When 
divided by age and gender, younger females are in greater risk of revision in 10 years. 
Inversion occurs when the primary replacement is made around 65 years of age in men, 
showing a slightly higher incidence of revision than women after 10 years [90, 93].
A lot of attention is given to the type of bearing nowadays. The most recent surfaces 
like ceramics, highly cross-linked polyethylene, and their combination with metal 
generate a lot of discussion in what would be the ideal, more durable surface, and for 
whom it should be use. Keeping aside the costs and a few laboratory assays, there is no 
real evidence in favor or against any of these, except for the metal-on-metal combina-
tion that has inferior outcomes in almost all the comparative published. In the 2014 
Australian report, ceramic combined with ceramic and highly cross-linked polyethyl-
ene had similar 10-year rates, 4.7 and 4.5%, respectively. The lower revision rate was 
metal on highly cross-linked polyethylene with 4.3% in 1 years. Any of these combina-
tions, when associated with an exchangeable femoral neck, showed two times higher 
rate of failure in that same period of time [93]. In the British reports, hybrid assembly 
with ceramic on polyethylene showed the outcome with 2.19% in 10 years [90].
The material that steams are made also has an influence in the outcomes as well 
as femoral head sizes. Pure titanium seems to have lower revision rates than titanium 
Hip Surgeries
14
and cobalt-chrome in the steam/neck material. Head sizes of 32 mm have a lower rate 
of revision than head sizes of 28 mm or less. However, there is no difference when 
head size 32 mm is compared to larger head size. This can probably be attributed to 
the higher incidence of dislocation that 28 mm or less heads present [93].
It has been advocated that total hip arthroplasty is probably the most success-
ful operative intervention performed by human beings. Still, a constant strive for 
innovation has a guide progress, especially in the technologic field. Every year more 
aspects are being reported, and a great volume of information has been gathered. 
More than never before, more patients, with a wider range of age and comorbidi-
ties, are having their hips replaced. The understanding of how this affects their lives 
and how to meet the changes in the demand and expectations for THA is an essen-
tial key to keep improving such celebrated medical procedure.
For this reason, patient-reported outcome measures (PROMs) are becoming 
increasingly important in the allocation of healthcare resources and the provision of 
guidelines for optimum care and management [89].The Swedish reports were pioneer 
in that area and are still improving the way to collect this information and how to pro-
cess that in numbers. In 2012 reports, patient satisfaction 1 year of THA (2010–2011) 
varied from 82.8 to 93.4%. They analyzed other variables such as pain relief, health-
related quality of life gained, 90-day mortality, coverage, reoperation within 2 years, 
5-year implant survival, 10-year implant survival, and set and nationwide standard 
for comparison with the obtained by institutions. The conclusions highlight the great 
challenge that it’s to organize the structure of information and engage the participants. 
Important influences were appointed related to anxiety and depression in the predictor 
of pain, pain relief, and patient satisfaction [98]. There’s no doubt that this patient-
related information will have an increasing role in the advanced hip arthroplasty.
6. Perspectives to the future
Although hip arthroplasty celebrates over 50 years since its creation, how the 
procedure has been slow in recent years. The main lines of research thus far devel-
oped are concentrated in areas that seek alternatives to metal implants, the use of 
new biomaterials, as well as the use of computer tools for planning and develop-
ment of surgery [99].
Several studies involving existing prostheses on the market seek to improve effi-
ciency by reducing the rejection or failure and to find synergy between the contact 
areas. With this, new surfaces, such as porous, the use of mesh titanium, and the 
development of metal-polyethylene interaction, are being researched [100, 101].
The area of biomaterials points to major advances. Examples are the use of hydroxy-
apatite for surface coating, the use of alternative bone graft as humans or bovine lyophi-
lized to assist in cases of bone loss, as well as the development of multidisciplinary 
techniques for bone regeneration, as in the case of VascuBone Project [102–104].
Among the computer tools for programming and development of surgery, the 
navigation techniques are the most researched. The main distinguishing feature of this 
feature is that it provides real-time measurements and precise alignments [105–109].
7. Conclusions
Regardless of the approach, the chosen implant, the THA surgery, is a major evo-
lution of modern medicine and came as a great benefit to patients. Every technique 
employed should be well studied, and the patient must always be the most benefited 
from the surgery.
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Nomenclature
OA osteoarthritis
THA total hip arthroplasty
DVT deep vein thrombosis
PMMA polymethyl methacrylate
Gpa gigapascal
UHMWPE ultrahigh-molecular-weight polyethylene
XLPE highly cross-linked polyethylene
ROM range of motion
LMWH low-molecular-weight heparin
SSI surgical site infection
PJI periprosthetic joint infection
TJA total joint arthroplasty
BMI body mass index
MRSA methicillin-resistant Staphylococcus aureus
MSSA methicillin-sensitive Staphylococcus aureus
UTI urinary tract infection
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CRP C-reactive protein
ESR erythrocyte sedimentation rate
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PROs patient-reported outcome
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